Diversified Trust CO Insmed Inc Transaction History

Diversified Trust CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 18, 2024	BUY	$25.72 - $29.94 $27,726 - $32,275	1,078 Added 5.23%	21,684 $588,000
Q4 2023 Jan 08, 2024	BUY	$23.42 - $31.74 $22,764 - $30,851	972 Added 4.95%	20,606 $638,000
Q3 2023 Nov 17, 2023	BUY	$19.86 - $26.93 $15,729 - $21,328	792 Added 4.2%	19,634 $495,000
Q1 2023 Apr 07, 2023	BUY	$16.26 - $21.73 $11,089 - $14,819	682 Added 3.76%	18,842 $321,000
Q4 2022 Jan 17, 2023	BUY	$16.98 - $23.15 $115,277 - $157,165	6,789 Added 59.7%	18,160 $363,000
Q3 2022 Oct 14, 2022	BUY	$20.88 - $28.21 $237,426 - $320,775	11,371 New	11,371 $245,000

467

182M

2.27M

3.33M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

Stay updated on Diversified Trust CO with notifications on news.